Jaime Masferrer
14Patents
10h-index
22Co-inventors
72Inventor score
Filing activity: Mar 24, 1988 → Jan 31, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5380738A | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents | Chemistry; Metallurgy | 89 | Expired |
| US6858598B1 | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | Human Necessities | 66 | Expired |
| US5972986A | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | Human Necessities | 64 | Expired |
| US6916800B2 | Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent | Human Necessities | 50 | Expired |
| US4906467A | Novel, long-duration treatment for glaucoma | Human Necessities | 35 | Expired |
| US6025353A | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents | Human Necessities | 29 | Expired |
| US6833373B1 | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | Human Necessities | 22 | Expired |
| US6689787B1 | Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia | Human Necessities | 19 | Expired |
| US6469040B2 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | Human Necessities | 18 | Expired |
| US5719163A | Substituted oxazolyl compounds for the treatment of inflammation | Chemistry; Metallurgy | 15 | Expired |
| US6649645B1 | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia | Human Necessities | 2 | Expired |
| US7772269B2 | Pyrazole analogs | Chemistry; Metallurgy | 1 | Active |
| US7320996B2 | Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer | Human Necessities | 0 | Expired |
| US11357777B2 | Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.